Home / Publication / Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

論文

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Author(s): Mohamed Elmeliegy, Joseph Chen, Aruna Dontabhaktuni, Allison Gaudy, Georgi I. Kapitanov, Junyi Li, Sabiha R. Mim, Sharad Sharma, Qin Sun, Sihem Ait-Oudhia

Year: 2024年7月4日

Accelerating Oncology Drug FDA Submission with Project Management Services

事例紹介

Quantitative Systems Pharmacology-Based Digital Twins Approach for Clinical Development in Rare Diseases

ウェビナー

モデルを活かした医薬品開発 (MIDD) が医薬品開発の危機的状況をどのように救ったか

事例紹介

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

ポスター

Powered by Translations.com GlobalLink Web Software

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Accelerating Oncology Drug FDA Submission with Project Management Services

Quantitative Systems Pharmacology-Based Digital Twins Approach for Clinical Development in Rare Diseases

モデルを活かした医薬品開発 (MIDD) が医薬品開発の危機的状況をどのように救ったか

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

メルマガ登録

クイックアクセス

ソリューション

お問合せ